PAPILLARY TUMOUR OF RENAL PELVIS

This adverse event was reported 12 times

These drugs are most commonly taken by patients reporting PAPILLARY TUMOUR OF RENAL PELVIS:

# Drug Count
0 METHOTREXATE 3
1 METHOTREXATE SODIUM 3
2 ADALIMUMAB 2
3 LITHIUM CARBONATE 2
4 METHYLPREDNISOLONE 2
5 ASPIRIN 1
6 ASPIRIN 325 MG 1
7 ASPIRIN 81 MG 1
8 AZATHIOPRINE 1
9 BISOPROLOL FUMARATE 1
See all common drugs associated with PAPILLARY TUMOUR OF RENAL PELVIS

PAPILLARY TUMOUR OF RENAL PELVIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CYSTEAMINE BITARTRATE 1 0.0010
1 CILOSTAZOL 1 0.0002
2 LITHIUM CARBONATE 2 0.0001
3 GOLIMUMAB 1 0.0001
4 SIROLIMUS 1 0.0001
5 MERCAPTOPURINE 1 0.0001
6 GLIMEPIRIDE 1 0.0000
7 METHYLPREDNISOLONE 2 0.0000
8 ROSUVASTATIN 1 0.0000
9 AZATHIOPRINE 1 0.0000
See all drugs enriched for association with PAPILLARY TUMOUR OF RENAL PELVIS

PAPILLARY TUMOUR OF RENAL PELVIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Phosphodiesterase 3 Inhibitor [EPC] 1 0.0002
1 Purine Antimetabolite [EPC] 1 0.0000
2 Sulfonylurea [EPC] 1 0.0000
3 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
4 Aldosterone Antagonist [EPC] 1 0.0000
5 Thiazide Diuretic [EPC] 1 0.0000
6 Vitamin D [EPC] 1 0.0000
7 Vitamin B12 [EPC] 1 0.0000
8 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
9 Vitamin C [EPC] 1 0.0000
See all drug classes enriched for association with PAPILLARY TUMOUR OF RENAL PELVIS